Article in Current opinion in biomedical engineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors.
Victor Hernandez-GordilloDepartment of Pathology, Division of Experimental Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Thomas Caleb CasolaroDepartment of Pathology, Division of Experimental Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Mo R EbrahimkhaniDepartment of Pathology, Division of Experimental Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Samira KianiDepartment of Pathology, Division of Experimental Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Funding
Pittsburgh Liver Research CenterP30DK120531 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Gavin E Arteel · 2019 to 2026
$10.9M
Recreating Human Developmental Hematopoietic Niches for Ex Vivo Biomanufacturing of Blood Stem CellsR01HL141805 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mo Reza Ebrahimkhani · 2019 to 2026
$2.6M
Integration of systems and synthetic biology to advance development of human tissues ex vivoR01EB028532 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EBRAHIMKHANI, MO REZA · 2019 to 2022
$1.7M
CRISPR logic circuits for safer and controllable gene therapiesR01EB024562 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KIANI, SAMIRA · 2018 to 2021
$1.7M
Multicell type human liver on chip microphysiological platform to examine CRISPR based gene modulationU01DK127713 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KIANI, SAMIRA · 2020 to 2022
$1.6M
Multicell type human liver on chip microphysiological platform to examine CRISPR- based gene modulation.U01EB029372 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KIANI, SAMIRA · 2019 to 2019
$589k
Multicell type human liver on chip microphysiological platform to examine CRISPR- based gene modulation.U01HL145794 · NHLBI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI KIANI, SAMIRA · 2018 to 2018
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Multicellular Systems to Translate Somatic Cell Genome Editors to Humans. · full record | OpenQuestion